Weight loss drugs may help obese teens have less suicidal thoughts, study finds
A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.
The FDA issued a warning about compounding pharmacies on weight-loss drugs
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies against skirting regulatory standards to put them on the market now that shortages are waning.
FDA says shortage of popular diabetes, weight-loss drugs resolved
The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved.
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and Drug Administration (FDA) said on Wednesday. Tirzepatide, currently marketed by Eli Lilly (LLY) as Mounjaro and Zepbound for diabetes and weight loss,
HealthDay on MSN1h
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk ...
tyla1d
Doctor issues devastating warning of ‘overlooked’ side effects of using Ozempic
Wylie said: "Ozempic (semaglutide) is a medication licensed for the management of type 2 diabetes. While it has shown ...
News Medical on MSN20h
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Medscape10h
Obesity Therapies: What Will the Future Bring?
Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...
News Medical on MSN22h
Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models
Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...
Woman on weight loss medicine calls Streeting ‘naive’ on anti-obesity jabs
A woman who takes weight loss medication has called Health Secretary Wes Streeting “naive” after he suggested weight-loss ...
ahajournals.org4d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, ...
Pharmaceutical Technology1mon
Glucagon Like Peptide 1 drugs in development, 2024
GlobalData’s report assesses the drugs in the Glucagon Like Peptide 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
NBC DFW6d
Surging demand leaves many without crucial diabetes and ADHD medications
Ozempic is in a class of medication called GLP-1, or glucagon-like peptide 1, agonists, which are primarily used to ...
Obesity care ‘insufficient’ as patients wait up to five years for care – report
Support for people living with obesity is “insufficient”, experts have said after a new report revealed that some patients ...
The American Journal of Managed Care5d
Legislative Updates, GLP-1s, and More at AMCP Nexus: Adam Colborn
Speakers from across the care continuum will discuss legislative updates, glucagon-like peptide-1 (GLP-1) use for weight management, and more at this year’s AMCP Nexus.